Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Acute kidney injury associated with glomerular diseases.

Fenoglio R, Sciascia S, Baldovino S, Roccatello D.

Curr Opin Crit Care. 2019 Dec;25(6):573-579. doi: 10.1097/MCC.0000000000000675.

PMID:
31689245
2.

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients.

Sciascia S, Cecchi I, Radin M, Rubini E, Suárez A, Roccatello D, Rodríguez-Carrio J.

Front Med (Lausanne). 2019 Sep 26;6:211. doi: 10.3389/fmed.2019.00211. eCollection 2019.

3.

Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study.

Radin M, Schreiber K, Sciascia S, Roccatello D, Cecchi I, Aguirre Zamorano MÁ, Cuadrado MJ.

Thromb Haemost. 2019 Dec;119(12):1920-1926. doi: 10.1055/s-0039-1696687. Epub 2019 Oct 6.

PMID:
31587246
4.

Nailfold Capillaroscopy Patterns.

Rossi D, Sciascia S, Roccatello D.

Isr Med Assoc J. 2019 Jul;21(7):497-498. No abstract available.

5.

The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience.

Radin M, Sciascia S, Cecchi I, Mengozzi G, Roccatello D.

Eur J Intern Med. 2019 Oct;68:e12-e14. doi: 10.1016/j.ejim.2019.07.026. Epub 2019 Aug 2. No abstract available.

PMID:
31378436
6.

[Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].

Manes M, Radin E, Pellu' V, Molino A A, Gabrielli D, Parodi E, Caputo D, Paternoster G, Barreca A, Pagliaro M, Quattrocchio G, Roccatello D.

G Ital Nefrol. 2019 Jul 24;36(4). pii: 2019-vol4. Italian.

PMID:
31373468
7.

Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.

Pérez-Sánchez C, Cecchi I, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Pérez-Sánchez L, Ibáñez-Costa A, Arias de la Rosa I, Ortega R, Escudero A, Castro MC, Radin M, Roccatello D, Sciascia S, Aguirre MÁ, Collantes E, López-Pedrera C; BIOSAR Study Group.

J Cell Mol Med. 2019 Sep;23(9):6308-6318. doi: 10.1111/jcmm.14517. Epub 2019 Jul 26.

8.

The dilemma of treating hepatitis C virus-associated cryoglobulinemia.

Roccatello D, Fenoglio R, Sciascia S.

Curr Opin Rheumatol. 2019 Sep;31(5):499-504. doi: 10.1097/BOR.0000000000000624.

PMID:
31090590
9.

Pregnancy outcomes in mixed connective tissue disease: a multicentre study.

Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro T, Andrade D, Gibbone E, Khamashta M, Buyon J, Izmirly P, Aguirre MA, Benedetto C, Roccatello D, Marozio L, Sciascia S.

Rheumatology (Oxford). 2019 Nov 1;58(11):2000-2008. doi: 10.1093/rheumatology/kez141.

PMID:
31079145
10.

Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS.

Arias de la Rosa I, Radin M, Cecchi I, Rubini E, Pérez-Sánchez C, Aguirre MÁ, Menegatti E, Barbarroja N, Collantes E, Sciascia S, Roccatello D, López Pedrera C.

Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166. No abstract available.

PMID:
31034051
11.

A Study to Explore the Parental Impact and Challenges of Self-Management in Children and Adolescents Suffering with Lymphedema.

Moffatt C, Aubeeluck A, Stasi E, Bartoletti R, Aussenac C, Roccatello D, Quere I.

Lymphat Res Biol. 2019 Apr;17(2):245-252. doi: 10.1089/lrb.2018.0077.

12.

[Extracorporeal therapy in sepsis].

Pozzato M, Livigni S, Roccatello D.

G Ital Nefrol. 2019 Apr;36(2). pii: 2019-vol2. Italian.

PMID:
30983171
13.

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.

Sciascia S, Radin M, Cecchi I, Rubini E, Scotta A, Rolla R, Montaruli B, Pergolini P, Mengozzi G, Muccini E, Baldovino S, Ferro M, Vaccarino A, Mahler M, Menegatti E, Roccatello D.

Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.

14.

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J; Conference Participants.

Kidney Int. 2019 Feb;95(2):281-295. doi: 10.1016/j.kint.2018.11.008.

15.

Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study.

Sciascia S, Yazdany J, Dall'Era M, Fenoglio R, Radin M, Aggarwal I, Cuadrado MJ, Schreiber K, Barreca A, Papotti M, Roccatello D.

Ann Rheum Dis. 2019 Jul;78(7):1004-1006. doi: 10.1136/annrheumdis-2018-214559. Epub 2018 Dec 14. No abstract available.

16.

ASIA Syndrome Following Breast Implant Placement.

Fenoglio R, Cecchi I, Roccatello D.

Isr Med Assoc J. 2018 Nov;20(11):714-716. No abstract available.

17.

Multifocal avascular osteonecrosis despite appropriate anticoagulation therapy in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Cecchi I, Pérez Sánchez L, Sciascia S, Roccatello D.

BMJ Case Rep. 2018 Nov 1;2018. pii: bcr-2018-225532. doi: 10.1136/bcr-2018-225532.

PMID:
30389732
18.

Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?

Enriquez Merayo E, Sciascia S, Roccatello D, Cuadrado MJ.

Expert Rev Clin Immunol. 2018 Nov;14(11):877-879. doi: 10.1080/1744666X.2018.1527219. Epub 2018 Oct 17. No abstract available.

PMID:
30328733
19.

Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.

Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.

Autoimmun Rev. 2018 Nov;17(11):1138-1149. doi: 10.1016/j.autrev.2018.06.006. Epub 2018 Sep 11. Review.

PMID:
30217550
20.

Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology.

Sciascia S, Radin M, Unlu O, Erkan D, Roccatello D.

Eur J Rheumatol. 2018 Jul;5(2):92-95. doi: 10.5152/eurjrheum.2018.17105. Epub 2018 Jan 22.

21.

Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients.

Radin M, Cecchi I, Rubini E, Schreiber K, Roccatello D, Mahler M, Sciascia S.

Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2. No abstract available.

PMID:
30096511
22.

Cryoglobulinaemia.

Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C.

Nat Rev Dis Primers. 2018 Aug 2;4(1):11. doi: 10.1038/s41572-018-0009-4. Review.

23.

Recent advances in the management of systemic lupus erythematosus.

Sciascia S, Radin M, Roccatello D, Sanna G, Bertolaccini ML.

F1000Res. 2018 Jun 29;7. pii: F1000 Faculty Rev-970. doi: 10.12688/f1000research.13941.1. eCollection 2018. Review.

24.

Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.

Cozzolino M, Bolasco P, Ronco C, Conte G, Menè P, Mereu MC, Di Luca M, Roccatello D, Rosati A, Jommi C, Costanzo AM, Gualberti G, di Luzio Paparatti U, Remuzzi G.

Nephron. 2018;140(1):39-47. doi: 10.1159/000490769. Epub 2018 Jul 17.

PMID:
30016767
25.

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome.

Fenoglio R, Sciascia S, Beltrame G, Mesiano P, Ferro M, Quattrocchio G, Menegatti E, Roccatello D.

Oncotarget. 2018 Jun 22;9(48):28799-28804. doi: 10.18632/oncotarget.25612. eCollection 2018 Jun 22.

26.

Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris.

Radin M, Roccatello D, Baldovino S, Sciascia S.

BMJ Case Rep. 2018 May 30;2018. pii: bcr-2017-223302. doi: 10.1136/bcr-2017-223302.

27.

Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab.

Sciascia S, Rubini E, Radin M, Cecchi I, Rossi D, Roccatello D.

Ann Rheum Dis. 2018 Nov;77(11):1694-1695. doi: 10.1136/annrheumdis-2018-213496. Epub 2018 May 18. No abstract available.

28.

IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy.

Quattrocchio G, Barreca A, Demarchi A, Solfietti L, Beltrame G, Fenoglio R, Ferro M, Mesiano P, Murgia S, Del Vecchio G, Massara C, Rollino C, Roccatello D.

Oncotarget. 2018 Apr 20;9(30):21337-21347. doi: 10.18632/oncotarget.25095. eCollection 2018 Apr 20.

29.

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome.

Sciascia S, Radin M, Cecchi I, Rubini E, Bazzan M, Roccatello D.

Semin Arthritis Rheum. 2019 Feb;48(4):741-744. doi: 10.1016/j.semarthrit.2018.04.001. Epub 2018 Apr 11.

30.

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"?

Radin M, Bertero L, Roccatello D, Sciascia S.

J Investig Med High Impact Case Rep. 2018 Feb 15;6:2324709618758347. doi: 10.1177/2324709618758347. eCollection 2018 Jan-Dec.

31.

Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis.

Sciascia S, Radin M, Sanna G, Cecchi I, Roccatello D, Bertolaccini ML.

Rheumatology (Oxford). 2018 Apr 1;57(4):661-665. doi: 10.1093/rheumatology/kex466. Review.

32.

Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort.

Roccatello D, Sciascia S, Rossi D, Naretto C, Bazzan M, Solfietti L, Sandrone M, Radin M, Baldovino S, Menegatti E.

Lupus. 2018 Jul;27(8):1393-1394. doi: 10.1177/0961203317751645. Epub 2018 Jan 11. No abstract available.

PMID:
29325491
33.

Immunological Rare Diseases.

Baldovino S, Menegatti E, Roccatello D, Sciascia S.

Adv Exp Med Biol. 2017;1031:497-509. doi: 10.1007/978-3-319-67144-4_26. Review.

PMID:
29214588
34.

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.

Radin M, Schreiber K, Cecchi I, Roccatello D, Cuadrado MJ, Sciascia S.

Eur J Neurol. 2018 Feb;25(2):320-325. doi: 10.1111/ene.13499. Epub 2017 Dec 2.

35.

Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).

Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A.

Arthritis Rheumatol. 2018 Jan;70(1):109-114. doi: 10.1002/art.40339. Epub 2017 Dec 1.

36.

Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.

Sciascia S, Radin M, Schreiber K, Fenoglio R, Baldovino S, Roccatello D.

Intern Emerg Med. 2017 Dec;12(8):1101-1108. doi: 10.1007/s11739-017-1753-2. Epub 2017 Sep 19. Review.

37.

The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.

Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Fenoglio R, Baldovino S, Menegatti E.

Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.

38.

"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.

Roccatello D.

Autoimmun Rev. 2017 Oct;16(10):995-998. doi: 10.1016/j.autrev.2017.07.015. Epub 2017 Aug 2.

39.

How I treat patients with systemic sclerosis in clinical practice.

Rossi D, Zanatta E, Marson P, Sciascia S, Polito P, Roccatello D, Cozzi F.

Autoimmun Rev. 2017 Oct;16(10):1024-1028. doi: 10.1016/j.autrev.2017.07.018. Epub 2017 Aug 1. Review.

40.

Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review.

Radin M, Cecchi I, Roccatello D, Meroni PL, Sciascia S.

Semin Thromb Hemost. 2018 Jul;44(5):466-474. doi: 10.1055/s-0037-1603936. Epub 2017 Aug 4. Review.

PMID:
28778105
41.

Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Sciascia S, Amigo MC, Roccatello D, Khamashta M.

Nat Rev Rheumatol. 2017 Sep;13(9):548-560. doi: 10.1038/nrrheum.2017.124. Epub 2017 Aug 3. Review.

42.

High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.

Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E.

Am J Nephrol. 2017;46(2):108-113. doi: 10.1159/000477944. Epub 2017 Jul 13.

43.

Radiotherapy in patients with HIV: current issues and review of the literature.

Alongi F, Giaj-Levra N, Sciascia S, Fozza A, Fersino S, Fiorentino A, Mazzola R, Ricchetti F, Buglione M, Buonfrate D, Roccatello D, Ricardi U, Bisoffi Z.

Lancet Oncol. 2017 Jul;18(7):e379-e393. doi: 10.1016/S1470-2045(17)30440-0. Review.

44.

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.

Roccatello D, Sciascia S, Rossi D, Naretto C, Bazzan M, Solfietti L, Baldovino S, Menegatti E.

BMJ Open. 2017 Jun 21;7(6):e015243. doi: 10.1136/bmjopen-2016-015243.

45.

HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies.

Schreiber K, Breen K, Cohen H, Jacobsen S, Middeldorp S, Pavord S, Regan L, Roccatello D, Robinson SE, Sciascia S, Seed PT, Watkins L, Hunt BJ.

Semin Thromb Hemost. 2017 Sep;43(6):562-571. doi: 10.1055/s-0037-1603359. Epub 2017 Jun 13. No abstract available.

PMID:
28609801
46.

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.

Roccatello D, Sciascia S, Rossi D, Solfietti L, Fenoglio R, Menegatti E, Baldovino S.

Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986. Review.

47.

Antiphospholipid antibodies: crossroads between autoimmunity and infections?

Sciascia S, Radin M, Bazzan M, Roccatello D.

Intern Emerg Med. 2017 Jun;12(4):557-558. doi: 10.1007/s11739-017-1664-2. Epub 2017 Apr 12. No abstract available.

48.

The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction.

Radin M, Schreiber K, Costanzo P, Cecchi I, Roccatello D, Baldovino S, Bazzan M, Cuadrado MJ, Sciascia S.

Int J Cardiol. 2017 Aug 1;240:72-77. doi: 10.1016/j.ijcard.2017.02.155. Epub 2017 Mar 24.

49.

Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials.

Sciascia S, Mompean E, Radin M, Roccatello D, Cuadrado MJ.

Clin Drug Investig. 2017 Jun;37(6):519-524. doi: 10.1007/s40261-017-0518-z. Review.

50.

International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, Antonelli A, Desbois AC, Comarmond C, Gragnani L, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV.

Autoimmun Rev. 2017 May;16(5):523-541. doi: 10.1016/j.autrev.2017.03.004. Epub 2017 Mar 7. Review.

Supplemental Content

Loading ...
Support Center